1. Case Challenges: Early and Intensive Type 2 Diabetes Treatment With Modern Agents

3. Management Guidelines for Hyperglycemia in Type 2 Diabetes

4. Management Guidelines for Hyperglycemia in Type 2 Diabetes (cont)

5. Case Study #1: Marcus

6. Case Discussion: Role of DPP-4 Inhibitors

7. DPP-4 Inhibitor Safety Concerns

8. Case Study #2: Joseph

9. Case Discussion: Role of SGLT2 Inhibitors

11. Other Warnings for SGLT2 Inhibitors

13. Cardiovascular Benefit With SGLT2 Inhibitors

14. Case Study #3: Emily

15. Case Discussion: Role of GLP-1 Agonists

16. GLP-1 Agonists Promote Weight Loss

17. LEADER: Cardiovascular Outcomes Trial With Liraglutide

18. Warnings for GLP-1 Agonists

19. Closing Remarks

20. Abbreviations